Damora Therapeutics, Inc. (DMRA)
NASDAQ: DMRA · Real-Time Price · USD
27.98
-0.16 (-0.59%)
Sep 2, 2026, 9:53 AM EDT - Market open
Damora Therapeutics Market Cap
Damora Therapeutics has a market cap or net worth of $1.73 billion as of September 2, 2026. Its market cap has increased by 40,902.13% in one year.
Market Cap
1.73B
Enterprise Value
1.19B
1-Year Change
40,902.13%
Ranking
Category
Stock Price
$27.98
ChartMarket Cap Chart
Since October 29, 2020, Damora Therapeutics's market cap has increased from $368.78M to $1.73B, an increase of 368.32%. That is a compound annual growth rate of 30.22%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 2, 2026 | 1.73B | 4,598.90% |
| Dec 31, 2025 | 36.75M | 500.17% |
| Dec 31, 2024 | 6.12M | -68.63% |
| Dec 29, 2023 | 19.52M | -33.64% |
| Dec 30, 2022 | 29.42M | -61.57% |
| Dec 31, 2021 | 76.54M | -75.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 29, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Taysha Gene Therapies | 1.85B |
| Lakefront Biotherapeutics NV | 1.85B |
| GH Research | 1.85B |
| Vir Biotechnology | 1.85B |
| Recursion Pharmaceuticals | 1.82B |
| Intellia Therapeutics | 1.78B |
| Septerna | 1.78B |
| Fortrea Holdings | 1.75B |